Skip to main content
. Author manuscript; available in PMC: 2011 Aug 1.
Published in final edited form as: J Thorac Oncol. 2010 Aug;5(8):1279–1284. doi: 10.1097/JTO.0b013e3181e2fcb0

Table 3.

Grade 3/4 Toxicity by dose level

Toxicity * 45 mg QD
G 3/4
(N=12)
30 mg QD
G 3/4
(N=13)
ALT/AST 2/0 1/0
Fatigue 2/2 4/0
Diarrhea 2/0 -
Hypertension 1/0 2/0
Proteinuria 2/0 1/0
Hand-foot syndrome 1/0 -
*

Events those were possible, probable or definitely related to study therapy